209 related articles for article (PubMed ID: 25916799)
1. Carcinogenicity of psychotropic drugs: A systematic review of US Food and Drug Administration-required preclinical in vivo studies.
Amerio A; Gálvez JF; Odone A; Dalley SA; Ghaemi SN
Aust N Z J Psychiatry; 2015 Aug; 49(8):686-96. PubMed ID: 25916799
[TBL] [Abstract][Full Text] [Related]
2. Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004-2013.
Vasudev A; Shariff SZ; Liu K; Burhan AM; Herrmann N; Leonard S; Mamdani M
Am J Geriatr Psychiatry; 2015 Dec; 23(12):1259-1269. PubMed ID: 26525997
[TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.
Fed Regist; 1998 Feb; 63(35):8983-6. PubMed ID: 12269370
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review.
Berry-Bibee EN; Kim MJ; Simmons KB; Tepper NK; Riley HE; Pagano HP; Curtis KM
Contraception; 2016 Dec; 94(6):650-667. PubMed ID: 27444984
[TBL] [Abstract][Full Text] [Related]
5. Impact of psychotropic drugs on suicide and suicidal behaviors.
Yerevanian BI; Choi YM
Bipolar Disord; 2013 Aug; 15(5):594-621. PubMed ID: 23869907
[TBL] [Abstract][Full Text] [Related]
6. Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.
Seoane-Vazquez E; Rodriguez-Monguio R; Hansen R
Clin Drug Investig; 2016 Apr; 36(4):281-92. PubMed ID: 26818406
[TBL] [Abstract][Full Text] [Related]
7. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011.
Stephenson CP; Karanges E; McGregor IS
Aust N Z J Psychiatry; 2013 Jan; 47(1):74-87. PubMed ID: 23144164
[TBL] [Abstract][Full Text] [Related]
8. Effects of psychotropic drugs on seizure threshold.
Pisani F; Oteri G; Costa C; Di Raimondo G; Di Perri R
Drug Saf; 2002; 25(2):91-110. PubMed ID: 11888352
[TBL] [Abstract][Full Text] [Related]
9. Thyroid adverse effects of psychotropic drugs: a review.
Bou Khalil R; Richa S
Clin Neuropharmacol; 2011; 34(6):248-55. PubMed ID: 21996646
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medications and the risk of fracture: a meta-analysis.
Takkouche B; Montes-Martínez A; Gill SS; Etminan M
Drug Saf; 2007; 30(2):171-84. PubMed ID: 17253881
[TBL] [Abstract][Full Text] [Related]
12. Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries.
Cantilino A; Lorenzo L; Paula Jdos A; Einarson A
Braz J Psychiatry; 2014; 36(2):106-10. PubMed ID: 24676044
[TBL] [Abstract][Full Text] [Related]
13. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports.
Alper K; Schwartz KA; Kolts RL; Khan A
Biol Psychiatry; 2007 Aug; 62(4):345-54. PubMed ID: 17223086
[TBL] [Abstract][Full Text] [Related]
14. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations.
Alldredge BK
Neurology; 1999; 53(5 Suppl 2):S68-75. PubMed ID: 10496236
[TBL] [Abstract][Full Text] [Related]
15. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
16. The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation.
Soffritti M; Padovani M; Tibaldi E; Falcioni L; Manservisi F; Belpoggi F
Am J Ind Med; 2014 Apr; 57(4):383-97. PubMed ID: 24436139
[TBL] [Abstract][Full Text] [Related]
17. The new guideline for evaluating effects of psychotropic drugs on the performance to drive a motor vehicle in Japan: Comparison with US FDA guideline.
Iwamoto K; Nakabayashi T; Yamaguchi A; Konishi Y; Saji M; Yoshimura R; Kanemoto K; Aoki H; Ando M; Ozaki N
Neuropsychopharmacol Rep; 2023 Jun; 43(2):172-176. PubMed ID: 37057649
[TBL] [Abstract][Full Text] [Related]
18. Weight considerations in psychotropic drug prescribing and switching.
Hasnain M; Vieweg WV
Postgrad Med; 2013 Sep; 125(5):117-29. PubMed ID: 24113670
[TBL] [Abstract][Full Text] [Related]
19. Clinically significant interactions of psychotropic agents with antipsychotic drugs.
Meyer MC; Baldessarini RJ; Goff DC; Centorrino F
Drug Saf; 1996 Nov; 15(5):333-46. PubMed ID: 8941495
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.
Hartz I; Skurtveit S; Steffenak AK; Karlstad Ø; Handal M
BMC Psychiatry; 2016 Jan; 16():12. PubMed ID: 26822371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
